SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
VULM Biotechnology
VULM Biotechnology Spółka z Ograniczoną Odpowiedzialnością
SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
VULM Biotechnology Spółka z Ograniczoną Odpowiedzialnością
VULM Biotechnology Spółka z Ograniczoną Odpowiedzialnością (KRS 0000438585, NIP 7010351816) is a Polish company, headquartered in Warszawa, Mazowieckie voivodeship. VULM BIOTECHNOLOGY operates in: Freight transport by road (PKD 49.41.Z). Industry: Land transport. The company has been listed in the National Court Register since October 31, 2012. VULM BIOTECHNOLOGY's most recently reported net revenue was 1.3 M PLN for 2019.
No arrears identified in the analyzed sources
No arrears or bankruptcy proceedings identified in the analyzed sources.
Main activity
49.41.ZFreight transport by road
Other activities
General codes (divisions and groups)
General codes indicate a PKD division or group without a specific subclass.
Credibility rating
48.5 / 100
Average credibility
Insolvency risk
Low
Elevated threat
Closure risk
12
/ 100
Risk comparison - scale 0 (safe) → 100 (critical)
No instability signals - ownership, management, PKD codes and company name remain relatively stable.
Shareholder changes
6
6/13 yrs
Board changes
1
1/13 yrs
PKD changes
4
4/13 yrs
Name changes
2
2/13 yrs
Data from 13 years of registry activity.
Payment reliability score from 2017–2019
Current: D (49/100)
Trend: stable (-0.3 pts/year)
Słaba wiarygodność płatnicza – wskaźniki finansowe sugerują podwyższone ryzyko opóźnień lub niewykonania zobowiązań.
Standard limit from 2017–2019
Current: 34.2 K PLN
Safe: 10.2 K PLN
Founded
October 31, 2012
13 years in operation
Legal form
SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
Registry: RejP
Headquarters
WARSZAWA
MAZOWIECKIE
Primary PKD
49.41.Z
Freight transport by road
Share capital
6.0 K PLN
120 shares total
Shareholders
2
shareholders
Board
1 person
Filed years
3 years
2017–2019
Registry entries
16
latest: January 12, 2023
Revenue
1.3 M PLN
2019
Net profit
6.2 K PLN
2019
Assets
438.0 K PLN
2019
Equity
82.2 K PLN
2019
EBITDA
N/A
2019
no depreciation data
Valuation
41.1 K PLN
Low confidence
Low confidence
Rate business credibility - VULM Biotechnology.
No ratings

Benchmark
In 2024 Polish courts declared 436 corporate bankruptcies - 10% more than in 2023 and almost 30% more than in 2022. Restructuring proceedings in the KRZ register jumped to 4,457 (+103% versus 2022). The most exposed sectors: construction, wholesale trade, transport, and hospitality. The full map, five-year trend, and sector breakdown.

Explainer
From 1 January 2026 the minimum monthly wage in Poland stands at PLN 4,806 gross (PLN 3,605.85 net) and PLN 31.40 gross per hour. The year-on-year increase is only PLN 140 - the smallest in years. For the first time since 2023, the act foresees no July adjustment, so the rate holds for the full year. The total employer cost of a minimum-wage worker is around PLN 5,790.28.

Ranking
Poland's top three employers - Jeronimo Martins/Biedronka, Grupa Orlen, and Poczta Polska - together supply over 211,000 jobs. Dino Polska sits close behind with 49,900 employees, having added more than 8,000 new positions in 2024. Six of the top 10 are State-Treasury–controlled. The full ranking, sector structure, and stories behind the headcount.

Benchmark
What does profitability look like in PKD section H (transport and storage) in 2024? Industry median, percentiles, regional standouts, and a list of the largest operators benchmarked against the market median.
Competing companies or those operating in the same market segment as VULM Biotechnology (in Warszawa, industry: Land transport).
WARSZAWA· Land transport
Revenue 2023: 981.9 M PLN
Answers to questions about the company's activity, registered office, identifiers, financial data, capital and control.
VULM BIOTECHNOLOGY's board has 1 member.
Latest reporting year
2019
Available years
8
Filing entries
0
16 historical registry entries for VULM Biotechnology
Filing document
Filing document
Commercial proxy change, Shareholder change
WA.XIII NS-REJ.KRS/68806/19/852
Filing documents submitted (3 documents)
Representation rule change, Commercial proxy change, Shareholder change, Articles of association amended
WA.XIII NS-REJ.KRS/57300/22/843